Metabolic Syndrome, Inflammation, and the Aging Process

Tagged:  

THERAPEUTICS
AGING -- Prevention
INSULIN
EICOSANOIDS
METABOLIC syndrome
OBESITY
HYPERTENSION

Abstract:The article offers information on the study concerning anti-aging therapy. The mode of treatment is relevant for the reduction of insulin and lipid mediator, eicosanoid, which is the prime cause for hormonal elevation in metabolic syndrome. This condition causes central obesity, prothrombic stage, atherogenic dyslipidemia, hyperinsulinemia, cardiac diseases and high blood pressure.

Share this with your friends
AttachmentSize
Metabolic Syndrome, Inflammation, and the Aging Process.pdf1.69 MB